Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 64
Filter
1.
Injury ; 52(4): 894-897, 2021 Apr.
Article in English | MEDLINE | ID: mdl-33143866

ABSTRACT

INTRODUCTION: The National Hip Fracture Database of England, Wales and Northern Ireland (NHFD) is the largest such database in the world. Data errors in within the NHFD lead to spurious evidence which ultimately informs Orthopaedic, Anaesthetic and Orthogeriatric clinical practice. MATERIALS AND METHODS: This multi-centre quality improvement study investigated, and sought to improve data inaccuracy within the NHFD. Hip arthroplasty episodes recorded between 2011-2020 were analysed for errors in operation, implant polarity and cementation. RESULTS: Inaccuracies were observed in 20.5% of 3972 data entries. Following the introduction of a hip fracture clinical data administrator in each centre, inaccuracies reduced four-fold (5.2% of 559 data entries). CONCLUSION: We advise caution when utilising NHFD data for research and audit purposes. In order to build a robust, accurate database for future research, we recommend the incorporation of specialist data administrators into the hip fracture multidisciplinary team.


Subject(s)
Hip Fractures , Databases, Factual , England , Hip Fractures/epidemiology , Hip Fractures/surgery , Humans , Northern Ireland , Wales
2.
Med. interna Méx ; 33(4): 503-510, jul.-ago. 2017. graf
Article in Spanish | LILACS | ID: biblio-894289

ABSTRACT

Resumen: La diabetes mellitus 2 es una epidemia mundial, aunado a esto, la nefropatía diabética se ha convertido en la principal causa de insuficiencia renal en etapa terminal. En los pacientes con diabetes mellitus 2 existe sobreexpresión de los cotransportadores de glucosa ligados a la vía del sodio tipo 2 (SGLT2) que contribuyen al mantenimiento de la hiperglucemia. Por tanto, los inhibidores de este transportador representan un tratamiento innovador independiente de la acción de la insulina o la función de las células beta pancreáticas. En estudios recientes se ha demostrado que los iSGLT2 tienen efectos benéficos en la microvasculatura, en especial en la progresión de la nefropatía diabética. Este efecto no sólo se debe a la mejora del control glucémico, sino también a efectos directos en el riñón. Los iSGLT2, al inducir la glucosuria, revierten la glucotoxicidad renal. En estudios experimentales se ha observado que, además, se reduce la hiperfiltración, así como los marcadores inflamatorios y fibróticos. También se ha visto reducción del volumen circulante efectivo y aumento en la actividad de bloqueadores del sistema renina-angiotensina-aldosterona (bloqueadores RAA) circulantes, creando así un efecto nefroprotector.


Abstract: Type 2 diabetes mellitus 2 (DM2) is already a worldwide epidemic, in addition, diabetic nephropathy has become the leading cause of end-stage renal failure. In patients with DM2 there is an increased expression of the sodium-glucose cotransporters 2 (SGLT2) that contribute to the maintenance of hyperglycemia. Therefore, the inhibitors of this transporter represent an innovative therapy independent of the action of insulin or the function of pancreatic beta cells. Recent studies have shown that iSGLT2 have beneficial effects on microvasculature, especially in the progression of diabetic nephropathy. This effect is due not only to improved glycemic control but also to direct effects on the kidney. iSGLT2 induce glycosuria to reverse renal glucotoxicity. In experimental studies it has been observed that, in addition, hyper-filtration as well as inflammatory and fibrotic markers are reduced. There has also been a reduction in effective circulating volume and an increase in the activity of circulating renin-angiotensin-aldosterone system blockers (RAA blockers), thus creating a nephroprotective effect.

3.
J Struct Biol ; 177(2): 329-34, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22245778

ABSTRACT

Structural biology studies typically require large quantities of pure, soluble protein. Currently the most widely-used method for obtaining such protein involves the use of bioinformatics and experimental methods to design constructs of the target, which are cloned and expressed. Recently an alternative approach has emerged, which involves random fragmentation of the gene of interest and screening for well-expressing fragments. Here we describe the application of one such fragmentation method, combinatorial domain hunting (CDH), to a target which historically was difficult to express, human MEK-1. We show how CDH was used to identify a fragment which covers the kinase domain of MEK-1 and which expresses and crystallizes significantly better than designed expression constructs, and we report the crystal structure of this fragment which explains some of its superior properties. Gene fragmentation methods, such as CDH, thus hold great promise for tackling difficult-to-express target proteins.


Subject(s)
MAP Kinase Kinase 1/chemistry , MAP Kinase Kinase 1/genetics , Protein Engineering , Cloning, Molecular , Crystallization , Crystallography , Escherichia coli , Humans , Peptide Fragments/biosynthesis , Peptide Fragments/chemistry , Peptide Fragments/isolation & purification , Protein Structure, Tertiary , Recombinant Proteins/biosynthesis , Recombinant Proteins/chemistry , Recombinant Proteins/isolation & purification
4.
J Dent Res ; 89(12): 1407-13, 2010 Dec.
Article in English | MEDLINE | ID: mdl-21098492

ABSTRACT

Wound healing within the oral mucosa results in minimal scar formation compared with wounds within the skin. We have recently demonstrated distinct differences in the aging profiles of cells (oral mucosal and patient-matched skin fibroblasts) isolated from these tissues. We hypothesized that the increased replicative potential of oral mucosal fibroblasts may confer upon them preferential wound-healing capacities. Passage-matched early cultures of oral mucosal fibroblasts and skin fibroblasts demonstrated distinct gene expression profiles, with several genes linked to wound healing/tissue repair. This was related to an increased ability of the 'replicatively younger' oral mucosal fibroblasts to repopulate a wound space and reorganize their surrounding extracellular matrix environment, key activities during the wound-healing process. We conclude that oral mucosal fibroblasts exhibit a preferential healing response in vivo, due to their 'replicatively younger' phenotype when compared with that of patient-matched skin fibroblasts.


Subject(s)
Fibroblasts/physiology , Mouth Mucosa/cytology , Case-Control Studies , Cell Count , Cell Culture Techniques , Cell Cycle/physiology , Cell Movement/physiology , Cell Proliferation , Cellular Senescence/physiology , Collagen/metabolism , Culture Media, Conditioned/analysis , Enzyme Precursors/analysis , Extracellular Matrix/physiology , Fibroblasts/cytology , Gelatinases/analysis , Gene Expression Profiling , Genotype , Humans , Matrix Metalloproteinase 2/analysis , Microarray Analysis , Mouth Mucosa/injuries , Phenotype , Regeneration/genetics , Regeneration/physiology , Skin/cytology , Wound Healing/genetics , Wound Healing/physiology
5.
J Dent Res ; 88(10): 916-21, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19783799

ABSTRACT

Oral mucosal wound-healing is characterized by rapid re-epithelialization and remodeling, with minimal scar formation. This may be attributed to the distinct phenotypic characteristics of the resident fibroblasts. To test this hypothesis, we investigated patient-matched oral mucosal and skin fibroblasts. Compared with skin fibroblasts, oral mucosal fibroblasts had longer proliferative lifespans, underwent more population doublings, and experienced senescence later, which was directly related to longer telomere lengths within oral mucosal fibroblasts. The presence of these longer telomeres was independent of telomerase expression, since both oral oral mucosal fibroblasts and skin fibroblasts were negative for active telomerase, as assessed according to the Telomeric Repeat Amplification Protocol. This study has demonstrated that, compared with skin fibroblasts, oral mucosal fibroblasts are 'younger', with a more embryonic/fetal-like phenotype that may provide a notable advantage for their ability to repair wounds in a scarless fashion.


Subject(s)
Fibroblasts/physiology , Mouth Mucosa/cytology , Telomerase/physiology , Case-Control Studies , Cell Count , Cell Proliferation , Cell Survival/physiology , Cells, Cultured , Cellular Senescence/physiology , Fibroblasts/cytology , Fibroblasts/enzymology , Humans , Mouth Mucosa/enzymology , Phenotype , Skin/cytology , Skin/enzymology , Telomere/ultrastructure , Wound Healing/physiology , beta-Galactosidase/analysis
6.
QJM ; 101(2): 155-8, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18194976

ABSTRACT

A formula derived from the Modification of Diet in Renal Disease (MDRD) study in chronic renal disease is widely used to estimate glomerular filtration rate (GFR). Recently a ten-year follow-up of MDRD participants evaluated four tests of kidney function measured at baseline as predictors of important long-term clinical outcomes. Surprisingly, neither formula-estimated GFR nor reference method GFR showed a clear advantage over simple creatinine measurement whereas another test, cystatin C, looked more promising. This raises important points of principle in terms of how the usefulness of test strategies should be assessed. Data on clinical outcomes are an essential ingredient in this process.


Subject(s)
Feeding Behavior , Glomerular Filtration Rate/physiology , Kidney Diseases/diet therapy , Outcome Assessment, Health Care/standards , Chronic Disease , Creatinine/blood , Cystatin C , Cystatins/blood , Feeding Behavior/physiology , Follow-Up Studies , Humans , Kidney Diseases/blood , Kidney Diseases/physiopathology , Kidney Function Tests/methods
7.
Clin Med (Lond) ; 7(4): 328-31, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17882846

ABSTRACT

The structure of medical records becomes ever more critical with the advent of electronic records. The Health Informatics Unit (HIU) of the Royal College of Physicians has two work streams in this area. The Records Standards programme is developing generic standards for all entries into medical notes and standards for the content of admission, handover and discharge records. The Information Laboratory (iLab) focuses on hospital episode statistics and their use for monitoring clinician performance. Clinician endorsement of the work is achieved through extensive consultations. Generic medical record-keeping standards are now available.


Subject(s)
Medical Records Systems, Computerized/standards , Episode of Care , Hospitals, Public , Humans , Medical Records Systems, Computerized/organization & administration , Quality Assurance, Health Care , Risk Management , State Medicine , United Kingdom
8.
Clin Med (Lond) ; 7(4): 332-8, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17882847

ABSTRACT

Hospital episode statistics were originally designed to monitor activity and allocate resources in the NHS. Recently their uses have widened to include analysis of individuals' activity, to inform appraisal and revalidation, and monitor performance. This study investigated physician attitudes to the validity and usefulness of these data for such purposes, and the effect of supporting individuals in data interpretation. A randomised study was conducted with consultant physicians in England, Wales and Scotland. The intervention group was supported by a clinician and an information analyst in obtaining and analysing their own data. The control group was unsupported. Attitudes to the data and confidence in their ability to reflect clinical practice were examined before and after the intervention. It was concluded that hospital episode statistics are not presently fit for monitoring the performance of individual physicians. A more comprehensive description of activity is required for these purposes. Improvements in the quality of existing data through clinical engagement at a local level, however, are possible.


Subject(s)
Attitude of Health Personnel , Employee Performance Appraisal/statistics & numerical data , Physicians/psychology , Employee Performance Appraisal/methods , Humans , State Medicine , Surveys and Questionnaires , United Kingdom
9.
Neuropharmacology ; 53(1): 58-70, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17543352

ABSTRACT

Group I metabotropic glutamate receptors (mGluRs) contribute to spinal sensitization and synaptic plasticity but the underlying mechanisms are unknown. Here, group I mGluR modulation of evoked monosynaptic excitatory postsynaptic currents (EPSCs) in substantia gelatinosa (SG) neurones in vitro was investigated in juvenile rats. In addition, the role of group I mGluRs in dorsal horn neuronal Fos expression was determined in tetrodotoxin (TTX)-treated in vitro spinal cords of naïve rats and those with Complete Freund's Adjuvant (CFA) peripheral inflammation. In the majority of SG neurones, (S)-3,5-dihydroxyphenylglycine (DHPG) reduced EPSCs and this effect was inhibited by the mGluR(5) antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP). Data for paired-pulse and spontaneous miniature excitatory postsynaptic currents (mEPSCs) suggest mGluR(5) acts presynaptically to reduce transmitter release. DHPG-induced reduction of EPSC amplitude operated via PKC, but not ERK, signalling cascade. In the dorsal horn of naïve but not CFA rats, DHPG increased Fos expression and this was reduced by MPEP and both PKC and ERK inhibitors. In the CFA group, basal Fos expression was reduced by MPEP and the kinase inhibitors. These data infer a role for mGluR(5) in acute modulation of nociceptive synaptic efficacy within the dorsal horn and postsynaptic activation of transcription factors such as Fos that are implicated in activity-dependent neuroplastic adaptation. These actions are achieved by differential activation of PKC- and ERK-dependent transduction pathways.


Subject(s)
Inflammation/pathology , Posterior Horn Cells/enzymology , Protein Kinases/metabolism , Receptors, Metabotropic Glutamate/physiology , Spinal Cord/pathology , Animals , Animals, Newborn , Dose-Response Relationship, Drug , Drug Interactions , Electric Stimulation/methods , Enzyme Activation/drug effects , Enzyme Inhibitors/pharmacology , Excitatory Amino Acid Antagonists/pharmacology , Female , Freund's Adjuvant , In Vitro Techniques , Inflammation/chemically induced , Male , Membrane Potentials/drug effects , Membrane Potentials/physiology , Membrane Potentials/radiation effects , Methoxyhydroxyphenylglycol/analogs & derivatives , Methoxyhydroxyphenylglycol/pharmacology , Oncogene Proteins v-fos/metabolism , Patch-Clamp Techniques/methods , Posterior Horn Cells/drug effects , Rats , Rats, Wistar
10.
Mol Microbiol ; 61(5): 1237-51, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16925557

ABSTRACT

Members of the soil-dwelling, sporulating prokaryotic genus Streptomyces are indispensable for the recycling of the most abundant polysaccharides on earth (cellulose and chitin), and produce a wide range of antibiotics and industrial enzymes. How do these organisms sense the nutritional state of the environment, and what controls the signal for the switch to antibiotic production and morphological development? Here we show that high extracellular concentrations of N-acetylglucosamine, the monomer of chitin, prevent Streptomyces coelicolor progressing beyond the vegetative state, and that this effect is absent in a mutant defective of N-acetylglucosamine transport. We provide evidence that the signal is transmitted through the GntR-family regulator DasR, which controls the N-acetylglucosamine regulon, including the pts genes ptsH, ptsI and crr needed for uptake of N-acetylglucosamine. Deletion of dasR or the pts genes resulted in a bald phenotype. Binding of DasR to its target genes is abolished by glucosamine 6-phosphate, a central molecule in N-acetylglucosamine metabolism. Extracellular complementation experiments with many bld mutants showed that the dasR mutant is arrested at an early stage of the developmental programme, and does not fit in the previously described bld signalling cascade. Thus, for the first time we are able to directly link carbon (and nitrogen) metabolism to development, highlighting a novel type of metabolic regulator, which senses the nutritional state of the habitat, maintaining vegetative growth until changing circumstances trigger the switch to sporulation. Our work, and the model it suggests, provide new leads towards understanding how microorganisms time developmental commitment.


Subject(s)
Acetylglucosamine/metabolism , Bacterial Proteins/metabolism , Phosphotransferases/metabolism , Streptomyces coelicolor/metabolism , Bacterial Proteins/genetics , Gene Expression Regulation, Bacterial/genetics , Genetic Complementation Test , Glucosamine/analogs & derivatives , Glucosamine/pharmacology , Glucose-6-Phosphate/analogs & derivatives , Glucose-6-Phosphate/pharmacology , Microscopy, Electron, Scanning/methods , Models, Biological , Mutation/genetics , Phenotype , Phosphotransferases/genetics , Protein Binding/drug effects , Regulon/genetics , Streptomyces coelicolor/genetics , Streptomyces coelicolor/ultrastructure , Substrate Specificity
11.
Clin Med (Lond) ; 5(1): 47-9, 2005.
Article in English | MEDLINE | ID: mdl-15745198

ABSTRACT

A review of data quality in the NHS by the Audit Commission cited a lack of clinician involvement in the validation and use of centrally held activity data as one of the key issues to resolve. The perception that hospital episode statistics cannot support the needs of the individual clinician results in mistrust and disinterest. This in turn leads to under-development of such data from a clinical perspective, and the cycle continues. The RCP Information Laboratory (iLab) aims to address this problem by accessing, analysing and presenting information from these central repositories concerning the activity of visiting individual consultant physicians. With support from iLab staff--an information analyst and a clinician--local data quality issues are highlighted and local solutions sought. The information obtained can be used as an objective measure of activity to support the processes of appraisal and revalidation.


Subject(s)
Data Collection , Forms and Records Control , Societies, Medical , Hospitalization/statistics & numerical data , Humans , Medical Audit , United Kingdom
12.
Dev Biol ; 279(1): 169-78, 2005 Mar 01.
Article in English | MEDLINE | ID: mdl-15708566

ABSTRACT

Herein, we investigated the role of VEGF signaling in the earliest events in vasculogenesis and found that it exerts critical effects shortly after mesodermal cells form by gastrulation. We showed that VEGF treatment of embryos caused an increase in the population of newly gastrulated mesodermal (NGM) cells that express the transcription factor TAL1. This increase in TAL1-positive cells was attributed to VEGF induction of VEGF receptor-2 (Flk1)-positive NGM cells that would normally not have been induced due to the limited availability of VEGF in the NGM. Evidence that VEGF-mediated induction of NGM cells is relevant to the endothelial lineage is the finding that induced TAL1-positive cells in the NGM formed ectopic structures whose cells exhibited characteristics of endothelial cells, including the ability to integrate into the vascular network and express the QH1 antigen. Finally, we showed that VEGF-induced TAL1 expression in the NGM which resulted in the formation of ectopic structures was mediated by Flk1 but not Flt1 signaling. In summary, we have established that VEGF signaling is critical to allocation of NGM to the endothelial lineage.


Subject(s)
Embryo, Nonmammalian/physiology , Endothelium, Vascular/embryology , Gastrula/physiology , Mesoderm/physiology , Vascular Endothelial Growth Factor A/pharmacology , Animals , Base Sequence , Coturnix/embryology , DNA Primers , Embryo, Nonmammalian/drug effects , Gastrula/drug effects , Gene Expression Regulation, Developmental/drug effects , Humans , Mesoderm/drug effects , RNA, Messenger/drug effects , RNA, Messenger/genetics , Recombinant Proteins/pharmacology , Reverse Transcriptase Polymerase Chain Reaction
13.
Bioorg Med Chem Lett ; 14(9): 2367-70, 2004 May 03.
Article in English | MEDLINE | ID: mdl-15081042

ABSTRACT

A series of 1-(1-indolinyl)-2-propylamines was synthesised and evaluated as 5-HT(2C) receptor agonists for the treatment of obesity. The general methods of synthesis of the precursor indoles are described. The functional efficacy and radioligand binding data for all of the compounds at 5-HT(2) receptor subtypes are reported. A number of compounds were found to reduce food intake in rats after oral administration.


Subject(s)
Anti-Obesity Agents/pharmacology , Indoles/pharmacology , Serotonin 5-HT2 Receptor Agonists , Serotonin Receptor Agonists/pharmacology , Animals , Anti-Obesity Agents/chemistry , Indoles/chemistry , Rats
14.
J Gen Virol ; 85(Pt 4): 821-831, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15039525

ABSTRACT

Infection of insect larvae with Autographa californica nucleopolyhedrovirus (AcMNPV) results in the liquefaction of the host, a process involving the action of virus-encoded chitinase and cathepsin gene products. Chitinase is localized in the endoplasmic reticulum (ER) during infection because of the presence of a C-terminal ER retrieval motif (KDEL). In this study, the KDEL coding region was removed from the chitinase gene so that expression of the modified chitinase remained under the control of its own gene promoter, at its native locus. The deletion of KDEL resulted in the redistribution of chitinase within the cell during virus infection. Chitinase lacking the KDEL motif was detectable at the plasma membrane and was also evident in the culture medium of virus-infected cells from as early as 12 h post-infection (p.i.). Secretion of chitinase from the cell continued up to 72 h p.i., until cytolysis. The biological activity of the recombinant virus in Trichoplusia ni larvae was enhanced, with a significant reduction in the lethal dose and lethal time associated with infection. Furthermore, a reduction in feeding damage caused by infected larvae was observed compared to AcMNPV-infected individuals.


Subject(s)
Chitinases/genetics , Nucleopolyhedroviruses/enzymology , Nucleopolyhedroviruses/genetics , Amino Acid Motifs , Amino Acid Sequence , Animals , Base Sequence , Cell Line , Chitinases/chemistry , Chitinases/metabolism , DNA, Viral/genetics , Genome, Viral , Molecular Sequence Data , Moths , Nucleopolyhedroviruses/pathogenicity , Oligopeptides , Protein Sorting Signals , Sequence Deletion , Spodoptera , Virulence
15.
Nucleic Acids Res ; 32(Database issue): D401-5, 2004 Jan 01.
Article in English | MEDLINE | ID: mdl-14681443

ABSTRACT

CADRE is a public resource for housing and analysing genomic data extracted from species of Aspergillus. It arose to enable maintenance of the complete annotated genomic sequence of Aspergillus fumigatus and to provide tools for searching, analysing and visualizing features of fungal genomes. By implementing CADRE using Ensembl, a framework is in place for storing and comparing several genomes: the resource will thus expand by including other Aspergillus genomes (such as Aspergillus nidulans) as they become available. CADRE is accessible at http://www.cadre. man.ac.uk.


Subject(s)
Aspergillus/genetics , Databases, Genetic , Genome, Fungal , Aspergillus fumigatus/genetics , Computational Biology , Genes, Fungal , Genomics , Information Storage and Retrieval , Internet , Software
16.
CMAJ ; 168(6): 669, 2003 Mar 18.
Article in English | MEDLINE | ID: mdl-12642411
17.
J Clin Pathol ; 55(7): 538-40, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12101204

ABSTRACT

This paper describes the case of a 48 year old man who presented with acute hyperlipidaemia following pulmonary embolism. Subsequent investigation revealed that the hyperlipidaemia was secondary to nephrotic syndrome of glomerulonephritis. The case illustrates the importance of investigating acute hyperlipidaemia for its underlying causes.


Subject(s)
Glomerulonephritis, Membranous/complications , Hyperlipidemias/etiology , Pulmonary Embolism/etiology , Acute Disease , Diagnosis, Differential , Humans , Male , Middle Aged , Nephrotic Syndrome/complications
18.
J Gen Virol ; 83(Pt 3): 685-694, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11842263

ABSTRACT

During virus infection of insect cells, the Autographa californica nucleopolyhedrovirus chitinase is localized primarily within the endoplasmic reticulum (ER), which is consistent with the presence of a carboxy-terminal ER retention motif (KDEL). Release of chitinase into the extracellular medium appears to be concomitant with terminal cell lysis, rather than by active secretion. In this study, we have shown that mutation of the KDEL motif induces a partial redistribution of the chitinase at both early and late times post-infection. Deletion of the KDEL motif or substitution with glycine residues allowed chitinase to move through the secretory pathway, accumulating to detectable levels in the extracellular medium by 24 h post-infection; more than 48 h prior to cell lysis. Deletion of the KDEL motif did not compromise enzyme activity, with the modified enzyme exhibiting characteristic endo- and exo-chitinolytic activity. Trichoplusia ni larvae infected with the modified virus were found to liquefy approximately 24 h earlier than larvae infected with a control virus in which the chitinase KDEL motif had not been deleted.


Subject(s)
Chitinases/chemistry , Chitinases/metabolism , Endoplasmic Reticulum/metabolism , Nucleopolyhedroviruses/enzymology , Nucleopolyhedroviruses/genetics , Oligopeptides/genetics , Protein Sorting Signals/genetics , Sequence Deletion/genetics , Amino Acid Motifs , Amino Acid Sequence , Amino Acid Substitution/genetics , Animals , Baculoviridae/genetics , Base Sequence , Cell Line , Chitinases/biosynthesis , Chitinases/genetics , Cysteine Endopeptidases/metabolism , Endoplasmic Reticulum/virology , Larva/growth & development , Larva/virology , Lepidoptera/growth & development , Lepidoptera/virology , Molecular Sequence Data , Nucleopolyhedroviruses/pathogenicity , Nucleopolyhedroviruses/physiology , Protein Transport , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Spodoptera , Survival Rate , Time Factors
19.
J Nutr ; 131(5): 1471-8, 2001 May.
Article in English | MEDLINE | ID: mdl-11340102

ABSTRACT

Early trials of garlic preparations on blood lipids mainly supported a lipid-lowering effect, whereas later well-designed garlic tablet trials were mainly entirely null. However, enteric simulation tests suggest that this discordance may result from ineffective delivery of bioactive agents from the brands of garlic powder (GP) and cyclodextrin-bound garlic oil (GO) tablets tested in some recent negative trials. In contrast, enteric simulation tests show that the preformed bioactive agents present in "traditional" gelatin capsules of GO are efficiently released, although such capsules have rarely been investigated in lipid-lowering trials. It was hypothesized that gelatin capsules of GO given to normal subjects would improve specified coronary heart disease risk factors. Effects of a GP preparation were also investigated. Subjects (n = 51; men and women, mean age 27 y) were randomly assigned to receive either 8.2 mg/d of GO (allyl sulfides) or placebo for 11 wk. Another 27 subjects received garlic powder (GP) of similar biopotential (7.8 mg allicin/d). Outcome measures were 95% confidence intervals (CI) between GO and placebo groups for differences between baseline and subsequent sample times. Men and women combined showed no significant differences save for an improved total antioxidant capacity at 6 wk (P = 0.01). Hence, no benefit from GO after 11 wk is one plausible conclusion. However, there were significant differences in effect of GO between men and women for HDL cholesterol (HDL-C) (P = 0.004) and total cholesterol (TC)/HDL-C (P = 0.003). Women showed favorable effects in terms of CHD risk factors (i.e., increases in HDL-C and reductions in TC/HDL-C), whereas men had small adverse effects. There was a significant difference in the GO effect for glucose (P = 0.006), with a reduction seen for men and an increase for women. The gender effects were unexpected and such analyses were not planned in advance. Confirmation of these findings with larger numbers of subjects would have importance for the use of garlic against CHD and for the design of future garlic studies.


Subject(s)
Allyl Compounds/pharmacology , Antioxidants/pharmacology , Blood Glucose/drug effects , Cholesterol/blood , Sulfides/pharmacology , Adult , Allyl Compounds/administration & dosage , Antioxidants/administration & dosage , Coronary Disease/prevention & control , Double-Blind Method , Female , Humans , Male , Middle Aged , Powders , Sex Factors , Sulfides/administration & dosage
20.
Blood Coagul Fibrinolysis ; 12(1): 67-74, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11229829

ABSTRACT

Most trials of bulb garlic and garlic powder tablets indicate reduced coronary heart disease (CHD) risk in elevated-risk subjects. Most persons taking garlic supplements lack overt risk of CHD. However, no trials have tested steam-distilled garlic oil (GO) capsules with healthy subjects. The objectives of the present randomized, double-blind, placebo-controlled study were to determine whether GO capsules reduce CHD risk in trained male runners. Twenty-seven volunteers (mean age, 28.8 years) completed the study. Each took 12.3 mg/day GO (or placebo) capsules for 16 weeks. Main outcome measures were 95% confidence intervals (CIs) between GO and placebo groups for differences in changes of blood pressure (BP), plasma lipids, total antioxidant status (TAS), low-density lipoprotein (LDL) composition and blood clotting factors. Principal results as mean differences (95% CI) between GO and placebo are: pulse, 2.9 beats/min (-0.8 to 6.7), P = 0.12; systolic BP, -4.5 mmHg (-10.8 to 1.9), P = 0.16; plasma total cholesterol, 0.01 mmol/l (-0.34 to 0.37), P = 0.95; plasma triglycerides, -0.20 mmol/l (-0.43 to 0.03), P = 0.09; plasma TAS, 45 micromol Trolox equivalent/l (-35 to 124), P = 0.26; LDL density, 0.0019 g/ml (-0.0005 to 0.0043), P = 0.12; LDL triglycerides/protein, -0.078 mg/mg (-0.149 to -0.007), P = 0.03; LDL cholesterol/protein, -0.24 mg/mg (-0.69 to 0.22), P = 0.3; LDL TAS/triglycerides, 29 nmol/mg (11, 68), P = 0.15; prothrombin time, 0.99 s (-0.36 to 2.35), P = 0.14; partial thromboplastin time, 3.0 s (-1.0 to 7.1), P = 0.13. Results were null statistically. Trends with GO were mostly towards lower CHD risk, and a larger study (approximately 150 subjects) is required to test their validity.


Subject(s)
Allyl Compounds/pharmacology , Coronary Disease/epidemiology , Coronary Disease/prevention & control , Running , Sulfides/pharmacology , Adolescent , Adult , Allyl Compounds/administration & dosage , Antioxidants/metabolism , Blood Pressure/drug effects , Coronary Disease/diet therapy , Double-Blind Method , Hemostasis/drug effects , Humans , Lipids/blood , Male , Middle Aged , Pulse , Risk Factors , Sulfides/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...